# Survey of Human Rabies Immune Globulin Safety in Children

> **NCT05382650** · — · TERMINATED · sponsor: **The Methodist Hospital Research Institute** · enrollment: 35 (actual)

## Conditions studied

- Rabies
- Rabies Human
- Rabies Virus Infection
- Pediatrics

## Interventions

- **BIOLOGICAL:** Human rabies immune globulin 300 IU/mL

## Key facts

- **NCT ID:** NCT05382650
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-22
- **Primary completion:** 2025-09-17
- **Final completion:** 2025-10-15
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2025-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05382650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05382650, "Survey of Human Rabies Immune Globulin Safety in Children". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05382650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*